These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 39231615)

  • 21. The Shelterin TIN2 Subunit Mediates Recruitment of Telomerase to Telomeres.
    Frank AK; Tran DC; Qu RW; Stohr BA; Segal DJ; Xu L
    PLoS Genet; 2015 Jul; 11(7):e1005410. PubMed ID: 26230315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Distinct functions of POT1 at telomeres.
    Barrientos KS; Kendellen MF; Freibaum BD; Armbruster BN; Etheridge KT; Counter CM
    Mol Cell Biol; 2008 Sep; 28(17):5251-64. PubMed ID: 18519588
    [TBL] [Abstract][Full Text] [Related]  

  • 23. RPA provides checkpoint-independent cell cycle arrest and prevents recombination at uncapped telomeres of Saccharomyces cerevisiae.
    Grandin N; Charbonneau M
    DNA Repair (Amst); 2013 Mar; 12(3):212-26. PubMed ID: 23312805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Shld1-controlled POT1a provides support for repression of ATR signaling at telomeres through RPA exclusion.
    Gong Y; de Lange T
    Mol Cell; 2010 Nov; 40(3):377-87. PubMed ID: 21070964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. E3 ligase RFWD3 participates in replication checkpoint control.
    Gong Z; Chen J
    J Biol Chem; 2011 Jun; 286(25):22308-13. PubMed ID: 21504906
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TFIIH moonlighting at telomeres.
    Glousker G; Lingner J
    Genes Dev; 2022 Sep; 36(17-18):951-953. PubMed ID: 36347559
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vivo stoichiometry of shelterin components.
    Takai KK; Hooper S; Blackwood S; Gandhi R; de Lange T
    J Biol Chem; 2010 Jan; 285(2):1457-67. PubMed ID: 19864690
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis.
    Kelich J; Aramburu T; van der Vis JJ; Showe L; Kossenkov A; van der Smagt J; Massink M; Schoemaker A; Hennekam E; Veltkamp M; van Moorsel CHM; Skordalakes E
    J Exp Med; 2022 May; 219(5):. PubMed ID: 35420632
    [TBL] [Abstract][Full Text] [Related]  

  • 29. G-quadruplex formation in telomeres enhances POT1/TPP1 protection against RPA binding.
    Ray S; Bandaria JN; Qureshi MH; Yildiz A; Balci H
    Proc Natl Acad Sci U S A; 2014 Feb; 111(8):2990-5. PubMed ID: 24516170
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TPP1 is a homologue of ciliate TEBP-beta and interacts with POT1 to recruit telomerase.
    Xin H; Liu D; Wan M; Safari A; Kim H; Sun W; O'Connor MS; Songyang Z
    Nature; 2007 Feb; 445(7127):559-62. PubMed ID: 17237767
    [TBL] [Abstract][Full Text] [Related]  

  • 31. POT1-TPP1 Binding and Unfolding of Telomere DNA Discriminates against Structural Polymorphism.
    Mullins MR; Rajavel M; Hernandez-Sanchez W; de la Fuente M; Biendarra SM; Harris ME; Taylor DJ
    J Mol Biol; 2016 Jul; 428(13):2695-708. PubMed ID: 27173378
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Human CTC1 promotes TopBP1 stability and CHK1 phosphorylation in response to telomere dysfunction and global replication stress.
    Ackerson SM; Gable CI; Stewart JA
    Cell Cycle; 2020 Dec; 19(24):3491-3507. PubMed ID: 33269665
    [TBL] [Abstract][Full Text] [Related]  

  • 33. RFWD3-Mediated Ubiquitination Promotes Timely Removal of Both RPA and RAD51 from DNA Damage Sites to Facilitate Homologous Recombination.
    Inano S; Sato K; Katsuki Y; Kobayashi W; Tanaka H; Nakajima K; Nakada S; Miyoshi H; Knies K; Takaori-Kondo A; Schindler D; Ishiai M; Kurumizaka H; Takata M
    Mol Cell; 2017 Jun; 66(5):622-634.e8. PubMed ID: 28575658
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular mechanisms of telomere biology disorders.
    Grill S; Nandakumar J
    J Biol Chem; 2021; 296():100064. PubMed ID: 33482595
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders.
    Norberg A; Rosén A; Raaschou-Jensen K; Kjeldsen L; Moilanen JS; Paulsson-Karlsson Y; Baliakas P; Lohi O; Ahmed A; Kittang AO; Larsson P; Roos G; Degerman S; Hultdin M
    Eur J Hum Genet; 2018 Jun; 26(6):858-867. PubMed ID: 29483670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. G-quadruplex-mediated regulation of telomere binding protein POT1 gene expression.
    He Q; Zeng P; Tan JH; Ou TM; Gu LQ; Huang ZS; Li D
    Biochim Biophys Acta; 2014 Jul; 1840(7):2222-33. PubMed ID: 24631651
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protection of telomeres 1 proteins POT1a and POT1b can repress ATR signaling by RPA exclusion, but binding to CST limits ATR repression by POT1b.
    Kratz K; de Lange T
    J Biol Chem; 2018 Sep; 293(37):14384-14392. PubMed ID: 30082315
    [TBL] [Abstract][Full Text] [Related]  

  • 38. TIN2 protein dyskeratosis congenita missense mutants are defective in association with telomerase.
    Yang D; He Q; Kim H; Ma W; Songyang Z
    J Biol Chem; 2011 Jul; 286(26):23022-30. PubMed ID: 21536674
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Telomere length, TERT and shelterin complex proteins in hepatocellular carcinomas expressing "stemness"-related markers.
    Kim H; Yoo JE; Cho JY; Oh BK; Yoon YS; Han HS; Lee HS; Jang JJ; Jeong SH; Kim JW; Park YN
    J Hepatol; 2013 Oct; 59(4):746-52. PubMed ID: 23685049
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A persistent variant telomere sequence in a human pedigree.
    Hinchie AM; Sanford SL; Loughridge KE; Sutton RM; Parikh AH; Gil Silva AA; Sullivan DI; Chun-On P; Morrell MR; McDyer JF; Opresko PL; Alder JK
    Nat Commun; 2024 Jun; 15(1):4681. PubMed ID: 38824190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.